Kim Fox is Emeritus Professor of Clinical Cardiology at the National Heart and Lung Institute, Imperial College London. He was Head of the National Heart and Lung Institute, Imperial College, from 2011 to 2018. He is also Diana, Princess of Wales Chair in Cardiovascular Medicine and Science and Consultant Cardiologist at the Royal Brompton Hospital. He is a Trustee of the National Heart and Lung Foundation as well as the Magdi Yacoub Institute. Professor Fox was also a non-Executive Director of the Royal Brompton and Harefield NHS Foundation Trust.
He was President of the European Society of Cardiology 2006-2008, having previously been Treasurer and Secretary. He was Associate Editor of the British Heart Journal in 1985-1994 and Editor in Chief of the European Heart Journal 1994-2002. He has previously served as a member of the British Heart Foundation Education Committee (chair), Council and Executive Committee as well as the British Cardiac Society’s Council and Medical Practice Committee (chair). He was a Founding Member of the Scientific Advisory Board of the Leducq Foundation as well as Broadview Ventures.
Professor Fox has published over 600 papers in leading scientific journals. His expertise is in the understanding, investigation and treatment of angina; in particular the role of heart rate in the pathophysiology of myocardial ischaemia and infarction. He has played a major role in many important international clinical trials (TIBET, EUROPA, IONA, BEAUTIFUL, SIGNIFY, CLARIFY, ATPCI, THEMIS etc) that have changed the treatment of this condition. He is the acknowledged European expert in this field and consequently chaired the Task Force producing the European Angina Guidelines and chaired the committee responsible for the audit for the management of these patients in Europe.
Professor Fox has given plenary lectures to National Societies all over the world. He has given the “Finlayson Lecture” to the Royal College of Surgeons in Glasgow, the “St Cyres Lecture” to the British Cardiac Society, the “Andrea Cissalpino Lecture” to the Italian Cardiac Society and the “Stokes Lecture” to the Irish Cardiac Society. Professor Fox has been elected an honorary member of the French Cardiac Society and Japanese Circulation Society for his services to cardiology. He has been awarded the Mackenzie Medal of the British Cardiovascular Society, the Gold Medal of the European Society of Cardiology, the Chazov Medal of the Russian Federation of Cardiology and the Stokes Medal of the Irish Cardiac Society.
et al., 2022, Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis, The Lancet Diabetes and Endocrinology, Vol:10, ISSN:2213-8595, Pages:645-654
et al., 2022, Balance of benefit and risk of ticagrelor in patients with diabetes and stable coronary artery disease according to bleeding risk assessment with the CRUSADE score: Data from THEMIS and THEMIS PCI., Am Heart J, Vol:249, Pages:23-33
et al., 2022, Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial, European Heart Journal-cardiovascular Pharmacotherapy, ISSN:2055-6837
et al., 2022, Balance of benefit and risk of ticagrelor in patients with diabetes and stable coronary artery disease according to bleeding risk assessment with the CRUSADE score: data from THEMIS and THEMIS PCI, American Heart Journal, ISSN:0002-8703
et al., 2022, Cardiovascular risk of chronic coronary syndrome patients according to vascular phenotype, diabetes and smoking, European Journal of Preventive Cardiology, Vol:29, ISSN:2047-4873, Pages:e35-e37